Cita APA (7a ed.)

RD, H. (2014). Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib. Dove Medical Press.

Cita Chicago Style (17a ed.)

RD, Harvey. Incidence and Management of Adverse Events in Patients with Relapsed And/or Refractory Multiple Myeloma Receiving Single-agent Carfilzomib. Dove Medical Press, 2014.

Cita MLA (8a ed.)

RD, Harvey. Incidence and Management of Adverse Events in Patients with Relapsed And/or Refractory Multiple Myeloma Receiving Single-agent Carfilzomib. Dove Medical Press, 2014.